{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T09:38:49Z","timestamp":1794908329361,"version":"4.9.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Canadian Institutes of Health Research (CIHR)","award":["MOP106665"],"award-info":[{"award-number":["MOP106665"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.freeradbiomed.2015.01.005","type":"journal-article","created":{"date-parts":[[2015,1,19]],"date-time":"2015-01-19T11:32:53Z","timestamp":1421667173000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF-\u03baB and MAPK signaling pathways"],"prefix":"10.1016","volume":"82","author":[{"given":"Ghada","family":"Abdelhamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.freeradbiomed.2015.01.005_bib1","first-page":"583","article-title":"Strategy for controlling rheumatic fever\/rheumatic heart disease, with emphasis on primary prevention: memorandum from a joint WHO\/ISFC meeting","volume":"73","author":"WHO","year":"1995","journal-title":"Bull. World Health Organ."},{"issue":"18","key":"10.1016\/j.freeradbiomed.2015.01.005_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa020265","article-title":"Long-term trends in the incidence of and survival with heart failure","volume":"347","author":"Levy","year":"2002","journal-title":"N. Eng. J. Med."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2015.01.005_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1157\/13087900","article-title":"[Cardiac hypertrophy: molecular and cellular events]","volume":"59","author":"Carreno","year":"2006","journal-title":"Rev. Esp. Cardiol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2015.01.005_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/01.CIR.97.1.48","article-title":"Prognostic significance of serial changes in left ventricular mass in essential hypertension","volume":"97","author":"Verdecchia","year":"1998","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.freeradbiomed.2015.01.005_bib5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2003.11.064","article-title":"Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study","volume":"43","author":"Drazner","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2015.01.005_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbagrm.2007.11.005","article-title":"Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2","volume":"1779","author":"Tanaka","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2015.01.005_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2015.01.005_bib8","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00402.2006","article-title":"Action of epoxyeicosatrienoic acids on cellular function","volume":"292","author":"Spector","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2015.01.005_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2015.01.005_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1-4","key":"10.1016\/j.freeradbiomed.2015.01.005_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prostaglandins.2011.08.001","article-title":"Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception","volume":"96","author":"Wagner","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2015.01.005_bib12","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1476-5381.2009.00461.x","article-title":"3-Methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats","volume":"158","author":"Aboutabl","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2015.01.005_bib13","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","article-title":"Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats","volume":"36","author":"Zordoky","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2015.01.005_bib14","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy","volume":"168","author":"Althurwi","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2015.01.005_bib15","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ng.129","article-title":"Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease","volume":"40","author":"Monti","year":"2008","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"Ai","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2015.01.005_bib17","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1021\/jm201468j","article-title":"Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications","volume":"55","author":"Shen","year":"2012","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2015.01.005_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/ars.2007.1474","article-title":"Cardiac hypertrophy: mechanisms and therapeutic opportunities","volume":"9","author":"Gupta","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2015.01.005_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/152308603770380034","article-title":"Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes","volume":"5","author":"Sabri","year":"2003","journal-title":"Antioxid. Redox Signal."},{"issue":"1464","key":"10.1016\/j.freeradbiomed.2015.01.005_bib20","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1098\/rstb.2005.1772","article-title":"NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology","volume":"360","author":"Cave","year":"2005","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2015.01.005_bib22","first-page":"173","article-title":"Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure","volume":"8","author":"Zhang","year":"2003","journal-title":"Exp. Clin. Cardiol."},{"issue":"21","key":"10.1016\/j.freeradbiomed.2015.01.005_bib23","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.1073\/pnas.0703229104","article-title":"Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo","volume":"104","author":"Ai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt 1","key":"10.1016\/j.freeradbiomed.2015.01.005_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bj3140115","article-title":"Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy","volume":"314","author":"Bogoyevitch","year":"1996","journal-title":"Biochem. J."},{"issue":"Pt 1","key":"10.1016\/j.freeradbiomed.2015.01.005_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj3470275","article-title":"Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro","volume":"347","author":"Aoki","year":"2000","journal-title":"Biochem. J."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2015.01.005_bib26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00004872-200018090-00017","article-title":"Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice","volume":"18","author":"Pellieux","year":"2000","journal-title":"J. Hypertens."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2015.01.005_bib27","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/01.RES.83.10.1035","article-title":"Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression","volume":"83","author":"Tsutsumi","year":"1998","journal-title":"Circ. Res."},{"issue":"12A","key":"10.1016\/j.freeradbiomed.2015.01.005_bib28","doi-asserted-by":"crossref","first-page":"64H","DOI":"10.1016\/S0002-9149(99)00261-1","article-title":"Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists","volume":"83","author":"Clerk","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"15","key":"10.1016\/j.freeradbiomed.2015.01.005_bib29","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Eng. J. Med."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2015.01.005_bib30","first-page":"1197","article-title":"Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress","volume":"5","author":"Meyskens","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib31","first-page":"589","article-title":"The NF-kappaB transcription factor in oncogenesis","volume":"16","author":"Sharma","year":"1996","journal-title":"Anticancer Res."},{"issue":"49","key":"10.1016\/j.freeradbiomed.2015.01.005_bib32","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"Xu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.freeradbiomed.2015.01.005_bib33","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2015.01.005_bib34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/CIRCRESAHA.110.226928","article-title":"Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB","volume":"108","author":"Gordon","year":"2011","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cvr\/cvs333","article-title":"Chronic depletion of glutathione exacerbates ventricular remodelling and dysfunction in the pressure-overloaded heart","volume":"97","author":"Watanabe","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"1-3","key":"10.1016\/j.freeradbiomed.2015.01.005_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejphar.2006.06.033","article-title":"Antioxidant N-acetylcysteine restores myocardial Mn-SOD activity and attenuates myocardial dysfunction in diabetic rats","volume":"544","author":"Xia","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2015.01.005_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.freeradbiomed.2015.01.005_bib39","series-title":"Molecular cloning: a laboratory Manual","author":"Sambrook","year":"1989"},{"issue":"9","key":"10.1016\/j.freeradbiomed.2015.01.005_bib40","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/nar\/19.9.2499","article-title":"A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells","volume":"19","author":"Andrews","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2015.01.005_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/dmd.105.007666","article-title":"The mitogen-activated protein kinase kinase (mek) inhibitor PD98059 elevates primary cultured rat hepatocyte glutathione levels independent of inhibiting mek","volume":"34","author":"Kim","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib42","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0735-1097(00)01123-2","article-title":"Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte","volume":"37","author":"Tanaka","year":"2001","journal-title":"J. Am. Coll Cardiol."},{"key":"10.1016\/j.freeradbiomed.2015.01.005_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yjmcc.2014.02.002","article-title":"Redox regulation of cardiac hypertrophy","volume":"73","author":"Sag","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00210-003-0849-6","article-title":"Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy","volume":"369","author":"Cheng","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2015.01.005_bib45","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.RES.87.5.392","article-title":"Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress","volume":"87","author":"Kinugawa","year":"2000","journal-title":"Circ. Res."},{"issue":"21","key":"10.1016\/j.freeradbiomed.2015.01.005_bib46","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/01.CIR.0000016721.84535.00","article-title":"Beneficial effects of long-term use of the antioxidant probucol in heart failure in the rat","volume":"105","author":"Sia","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.freeradbiomed.2015.01.005_bib47","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/eurheartj\/14.11.1493","article-title":"Evidence of oxidative stress in chronic heart failure in humans","volume":"14","author":"McMurray","year":"1993","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2015.01.005_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/hc0402.102863","article-title":"Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy","volume":"105","author":"Hirotani","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2015.01.005_bib49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cardiores.2005.02.007","article-title":"Blockade of NF-kappaB improves cardiac function and survival without affecting inflammation in TNF-alpha-induced cardiomyopathy","volume":"66","author":"Kawamura","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2015.01.005_bib50","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.01175.2005","article-title":"Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction","volume":"291","author":"Kawano","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2015.01.005_bib51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/08941930903040155","article-title":"Searching for NF-kappaB-based treatments of ischemia reperfusion injury","volume":"22","author":"Latanich","year":"2009","journal-title":"J. Invest. Surg."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2015.01.005_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1096\/fj.07-104109","article-title":"Oxidative, multistep activation of the noncanonical NF-kappaB pathway via disulfide Bcl-3\/p50 complex","volume":"23","author":"Cristofanon","year":"2009","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2015.01.005_bib53","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1084\/jem.175.5.1181","article-title":"Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells","volume":"175","author":"Schreck","year":"1992","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.freeradbiomed.2015.01.005_bib54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jphotobiol.2014.05.010","article-title":"Pyrrolidine dithiocarbamate inhibits UVB-induced skin inflammation and oxidative stress in hairless mice and exhibits antioxidant activity in vitro","volume":"138C","author":"Ivan","year":"2014","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.freeradbiomed.2015.01.005_bib55","first-page":"1","article-title":"Effect of ammonium pyrrolidine dithiocarbamate (PDTC) on NF-kappaB activation and CYP2E1 content of rats with immunological liver injury","author":"Qin","year":"2014","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib56","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjp.0704463","article-title":"Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation","volume":"135","author":"Cuzzocrea","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"55","key":"10.1016\/j.freeradbiomed.2015.01.005_bib57","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1038\/sj.onc.1205977","article-title":"Identification of radiation-specific responses from gene expression profile","volume":"21","author":"Park","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib58","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1074\/jbc.M307521200","article-title":"Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression","volume":"279","author":"Jiang","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"6642","key":"10.1016\/j.freeradbiomed.2015.01.005_bib59","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/41493","article-title":"A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB","volume":"388","author":"DiDonato","year":"1997","journal-title":"Nature"},{"issue":"5412","key":"10.1016\/j.freeradbiomed.2015.01.005_bib60","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.284.5412.271","article-title":"IkappaB kinases: kinsmen with different crafts","volume":"284","author":"May","year":"1999","journal-title":"Science"},{"issue":"46","key":"10.1016\/j.freeradbiomed.2015.01.005_bib61","doi-asserted-by":"crossref","first-page":"27489","DOI":"10.1074\/jbc.270.46.27489","article-title":"PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo","volume":"270","author":"Alessi","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.freeradbiomed.2015.01.005_bib62","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1073\/pnas.92.17.7686","article-title":"A synthetic inhibitor of the mitogen-activated protein kinase cascade","volume":"92","author":"Dudley","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.freeradbiomed.2015.01.005_bib63","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.0000138190.50127.6A","article-title":"Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload","volume":"110","author":"Harris","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cellsig.2005.04.005","article-title":"Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes","volume":"18","author":"Clerk","year":"2006","journal-title":"Cell Signal."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2015.01.005_bib65","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.yjmcc.2006.04.011","article-title":"Using U0126 to dissect the role of the extracellular signal-regulated kinase 1\/2 (ERK1\/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes","volume":"41","author":"Kennedy","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2015.01.005_bib66","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/aps.2013.185","article-title":"Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1\/2, p38 and NF-kappaB pathways","volume":"35","author":"Chen","year":"2014","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089158491500012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089158491500012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:23:27Z","timestamp":1760203407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089158491500012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":66,"alternative-id":["S089158491500012X"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.01.005","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF-\u03baB and MAPK signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}